122 related articles for article (PubMed ID: 7651868)
1. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient.
Perez-Benavides F; Riff E; Franks C
Pediatr Emerg Care; 1995 Jun; 11(3):153-5. PubMed ID: 7651868
[TBL] [Abstract][Full Text] [Related]
2. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
Weg JG; Balk RA; Tharratt RS; Jenkinson SG; Shah JB; Zaccardelli D; Horton J; Pattishall EN
JAMA; 1994 Nov; 272(18):1433-8. PubMed ID: 7933425
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of ARDS with two doses of synthetic surfactant.
Heikinheimo M; Hynynen M; Rautiainen P; Andersson S; Hallman M; Kukkonen S
Chest; 1994 Apr; 105(4):1263-4. PubMed ID: 8162762
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
Doig C
JAMA; 1995 Apr; 273(16):1259-60. PubMed ID: 7715036
[No Abstract] [Full Text] [Related]
6. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
[TBL] [Abstract][Full Text] [Related]
7. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
8. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
[TBL] [Abstract][Full Text] [Related]
9. Consensus on surfactant and inhaled nitric oxide for ARDS.
Gadek JE
J Aerosol Med; 1996; 9(1):155-62. PubMed ID: 10160205
[TBL] [Abstract][Full Text] [Related]
10. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
Sanghvi KP; Merchant RH
Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
[No Abstract] [Full Text] [Related]
11. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Robertson B; Sangstad OD
Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
[No Abstract] [Full Text] [Related]
12. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
[No Abstract] [Full Text] [Related]
13. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
14. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Abbasi S; Bhutani VK; Gerdes JS
J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
Bhutani VK; Abbasi S; Long WA; Gerdes JS
J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
[TBL] [Abstract][Full Text] [Related]
16. Surfactant therapy in respiratory distress syndrome--the first local experience.
Lim NL; Nordin MM; Cheah IG
Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
[TBL] [Abstract][Full Text] [Related]
17. The instillated surfactant in the treatment of sepsis-induced ARDS: case report.
Imperatore F; Postiglione M; Diurno F; Cirillo F; Liguori G; Pica M
Intensive Care Med; 1999 Mar; 25(3):330-1. PubMed ID: 10229173
[No Abstract] [Full Text] [Related]
18. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Levine D; Edwards DK; Merritt TA
AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
[TBL] [Abstract][Full Text] [Related]
19. Comparing surfactant products.
Prevost RR
Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
[No Abstract] [Full Text] [Related]
20. Energy expenditure during synthetic surfactant replacement therapy for neonatal respiratory distress syndrome.
Hazan J; Chessex P; Piedboeuf B; Bourgeois M; Bard H; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S29-33. PubMed ID: 1735848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
